Find clinical trials for Breast Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near New York, NY, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple ne ...
Phase 1
New York, New York, United States and 8 other locations
study drug, Nivolumab as a possible treatment for triple-negative breast cancer that has spread to other parts of the body.The inte...
Phase 2
Stamford, Connecticut, United States and 9 other locations
radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...
Phase 2
New York, New York, United States and 5 other locations
Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatment naive ...
Phase 1
New York, New York, United States and 2 other locations
participants with early-stage high-risk hormone receptor positive breast cancer.The names of the study drugs involved in this study...
Phase 2
Stamford, Connecticut, United States and 9 other locations
This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...
Phase 2
Stamford, Connecticut, United States and 10 other locations
This research study is for patients with metastatic breast cancer.Metastatic means that the cancer has spread beyond the b...
Phase 2
New York, New York, United States and 19 other locations
The goal of this protocol is to evaluate the safety and efficacy of an alternative systemic combination approach that omits or delays the use of chem...
Phase 2
New York, New York, United States and 1 other location
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:A combi...
Phase 2
New York, New York, United States and 25 other locations
This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...
Phase 2
New York, New York, United States and 12 other locations
Clinical trials
Research sites
Resources
Legal